CardioGenics Holdings Inc (CGNH)

Market Cap	28.57K
Revenue (ttm)	n/a
Net Income (ttm)	-980.79K
Shares Out	142.86M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,100
Average Volume	1,889
Open	0.0001
Previous Close	0.0002
Day's Range	0.0001 - 0.0002
52-Week Range	0.0001 - 0.0002
Beta	82.98
RSI	77.84
Earnings Date	n/a

About CardioGenics Holdings

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are u...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CGNH